You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Clinical utility of transperineal template-guided mapping prostate biopsy in a selection of patients under active surveillance and confirmation of patients with negative biopsy for prostate cancer
- 2. A review on the role of MiR-193a-5p in oncogenesis and tumor progression
- 3. Exercise key to improving sexual dysfunction for patients with prostate cancer
- 4. Blue Earth's radioligand therapy achieves high tumour radiation absorption
- 5. Drug more than doubles survival time for glioblastoma patients
- 6. Do firefighters face a higher brain cancer risk associated with gene mutations caused by chemical exposure?
- 7. Researchers develop drug found to more than double survival time for glioblastoma patients
- 8. New test identifies high-risk childhood brain tumors, improving treatment decisions
- 9. Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma
- 10. New test identifies high-risk childhood brain tumours, improving treatment decisions
Last updated at 1:04 GMT
Hot News Makers
Health/Pharma Companies
-
60273.60
-
30525.30
-
22044.14
-
13799.23
-
12346.03
-
11431.51
-
11102.55
-
10401.33
-
10125.19
-
7698.77
Drugs, Treatments, Trials
-
22951.64
-
15709.93
-
12100.83
-
10266.52
-
7842.56
-
7746.76
-
6778.41
-
6253.96
-
5552.09
-
4106.53
Last updated at 0:10 GMT
